Immune targeting strategy using anti-IL-7R antibody-drug conjugate (A7R-ADC)

被引：0

作者：

Yang, Shiqi ^{[1
]}

Manabe, Shino ^{[2
]}

Yasunaga, Masahiro

机构：

[1] Natl Canc Ctr, EOR&CT Ctr, Div Dev Therap, Tokyo, Japan

[2] Hoshi Univ, Dept Pharm, Lab Funct Mol Chem, Tokyo, Japan

来源：

CANCER SCIENCE | 2021年 / 112卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PJ12-5-3

引用

页码：744 / 744

页数：1

共 50 条

[21] Targeting the IL-7R pathway in leukemia
Durum, Scott Kenneth
Hixon, Julie
Senkevitch, Emilee
Cramer, Sarah
Barata, Joao
Walsh, Scott
Li, Wenqing
CYTOKINE, 2015, 76 (01) : 76 - 76
[22] Targeting the IL-7R pathway in leukemia
Durum, Scott
Hixon, Julie
Senkevitch, Emilee
Cramer, Sarah
Barata, Joao
Walsh, Scott
Li, Wenqing
CYTOKINE, 2017, 100 : 181 - 181
[23] Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Pemmaraju, Naveen
Martinelli, Giovanni
Todisco, Elisabetta
Lane, Andrew A.
Acuna-Cruz, Evelyn
Deconinck, Eric
Wang, Eunice S.
Sweet, Kendra L.
Rizzieri, David A.
Mazzarella, Luca
DeAngelo, Daniel J.
Montesinos, Pau
Tarella, Corrado
Erba, Harry P.
Konopleva, Marina
Kantarjian, Hagop M.
Sloss, Callum M.
Malcolm, Kara E.
Zweidler-McKay, Patrick A.
Daver, Naval
BLOOD, 2020, 136
[24] Biodistribution and Targeting of Anti-5T4 Antibody-Drug Conjugate Using Fluorescence Molecular Tomography
Giddabasappa, Anand
Gupta, Vijay R.
Norberg, Rand
Gupta, Parul
Spilker, Mary E.
Wentland, Joann
Rago, Brian
Eswaraka, Jeetendra
Leal, Mauricio
Sapra, Puja
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (10) : 2530 - 2540
[25] Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
Kong, Fan-En
Li, Guang-Meng
Tang, Yun-Qiang
Xi, Shao-Yan
Loong, Jane Ho Chun
Li, Mei-Mei
Li, Hao-Long
Cheng, Wei
Zhu, Wen-Jie
Mo, Jia-Qiang
Gong, Yuan-Feng
Tang, Hui
Zhao, Yue
Zhang, Yan
Ma, Stephanie
Guan, Xin-Yuan
Ma, Ning-Fang
Xie, Mao-Bin
Liu, Ming
SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (579)
[26] A phase II study of glembatumumab vedotin (GV), an antibody-drug conjugate (ADC) targeting gpNMB, in advanced melanoma
Ott, Patrick Alexander
Pavlick, Anna C.
Johnson, Douglas Buckner
Hart, Lowell L.
Infante, Jeffrey R.
Luke, Jason John
Lutzky, Jose
Rothschild, Neal Evan
Spitler, Lynn E.
Cowey, Charles Lance
Alizadeh, Aaron
Salama, April K.
Yin, Xiaoyan
Bagley, Rebecca G.
Wang, Ying
Hamid, Omid
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[27] A phase 2 study of glembatumumab vedotin (GV), an antibody-drug conjugate (ADC) targeting gpNMB, in advanced melanoma
Ott, P. A.
Pavlick, A. C.
Johnson, D. B.
Hart, L. L.
Infante, J. R.
Luke, J. J.
Lutzky, J.
Rothschild, N.
Spitler, L.
Cowey, C. L.
Alizadeh, A.
Salama, A.
He, Y.
Bagley, R. G.
Zhang, J.
Hamid, O.
ANNALS OF ONCOLOGY, 2016, 27
[28] Generation of an antibody-drug conjugate-optimized TLR 7/8 agonist payload
Wang, Kung-Pern
Neumann, Chris
Epp, Angela
Zeng, Weiping
Griffith, Thomas
Ferguson, David
Gardai, Shyra
Smith, Alyson J.
CANCER RESEARCH, 2023, 83 (07)
[29] IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
Ceausu, Andra
Rodriguez-Gallego, Esther
Peraire, Joaquim
Lopez-Dupla, Miguel
Domingo, Pere
Vilades, Consuelo
Vidal-Gonzalez, Judit
Peraire, Maria
Perpinan, Carles
Maria Pacheco, Yolanda
Veloso, Sergi
Alba, Veronica
Vargas, Montserrat
Castellano, Alfonso J.
Ruiz-Mateos, Ezequiel
Mallolas, Josep
Vidal, Francesc
Rull, Anna
SCIENTIFIC REPORTS, 2019, 9 (1)
[30] IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
Andra Ceausu
Esther Rodríguez-Gallego
Joaquim Peraire
Miguel López-Dupla
Pere Domingo
Consuelo Viladés
Judit Vidal-Gonzalez
Maria Peraire
Carles Perpiñán
Yolanda María Pacheco
Sergi Veloso
Verónica Alba
Montserrat Vargas
Alfonso J. Castellano
Ezequiel Ruiz-Mateos
Josep Mallolas
Francesc Vidal
Anna Rull
Scientific Reports, 9

← 1 2 3 4 5 →